Chenxiang Xu

机构：Kunming Medical University · ORCID：0009-0001-3047-1554

发表论文 11 篇 · 总被引 88 次 · h-index 6

代表论文

• Clinical significance of EPHX2 deregulation in prostate cancer (2020 · Asian Journal of Andrology · 被引 24)
• The functional implication of ATF6α in castration‐resistant prostate cancer cells (2023 · The FASEB Journal · 被引 20)
• Long Non-coding RNA AGAP2-AS1 Silencing Inhibits PDLIM5 Expression Impeding Prostate Cancer Progression via Up-Regulation of MicroRNA-195-5p (2020 · Frontiers in Genetics · 被引 19)
• IDO promotes the proliferation and invasion of prostate cancer cells through KYNU (2022 · Genes & Genomics · 被引 9)
• Pro-oncogene FBI-1 inhibits the ferroptosis of prostate carcinoma PC-3 cells via the microRNA-324-3p/GPX4 axis (2024 · Journal of Cancer · 被引 7)
• The SDF‐1/CXCR4 axis is involved in adipose‐derived stem cell migration (2024 · Neurourology and Urodynamics · 被引 6)